Comparison of Current Subgingival Debridement Methods

February 14, 2025 updated by: Selcen Ozcan Bulut, Hacettepe University

Comparison of Current Subgingival Debridement Methods: Clinical Trial with 6 Months Follow-up

Our study aimed to compare the effectiveness of current subgingival debridement methods used in the treatment of Stage 1 and Stage 2 periodontitis patients, the aesthetic condition achieved after these treatments, and the pain felt during treatment.

90 female patients who were diagnosed with chronic periodontitis (Stage 1-2) and required supra-subgingival scaling for treatment purposes, and who volunteered to participate in the study, were included in the study. Three treatment groups were determined. 30 people were included in each group. Periodontal examination was performed before and after the treatments in the 1st month, 3rd month and 6th month and the data on the collected periodontal parameters were analyzed.

Study Overview

Detailed Description

Periodontal parametreler Gingival index, plaque index, periodontal pocket depth and bleeding index on probing.

It was evaluated with the visual analog scale for pain and aesthetics.

Study Type

Observational

Enrollment (Actual)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Niğde, Turkey
        • Nigde Omer Halisdemir University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

90 female patients with stage 1-2 periodontitis

Description

Inclusion Criteria:

  • Systemically healthy patient (without known chronic disease)
  • Periodontal diagnostic data (Gingival Index, Plaque Index, Periodontal pocket depths, Attachment loss, Radiological data-Bone loss data) are complete
  • Treatments diagnosed with stage 1-2 periodontitis and those who have not had periodontal treatment in the last 6 months

Exclusion Criteria:

  • Having a systemic disease
  • Pregnant and lactating women
  • smoker
  • Those who do not want to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Group 1- classic treatment
Subgingival debridement was performed using the Cavitron and Gracey curette (this is the method that is used routinely).
Group 2-Guided Biofilm Therapy
Subgingival debridement was performed with the Guided Biofilm Therapy (GBT+Airabrasion) method. This method is the most up-to-date method. The biofilm is shown to the patient with plate dye, and the biofilm is cleaned with air abrasion and perio flow (EMS device cavitron). In the patient's control sessions, the patient's oral hygiene motivation is tried to be increased by dyeing the biofilm.
Group 3- Classical treatment and with Plaque paint
the dental calculus and biofilm were stained with plaque paint, shown to the patient with the help of a mirror, and then routine subgingival debridement was performed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gingival index
Time Frame: baseline, 1st month, 3rd month and 6th month

4 surfaces of all teeth (distal, buccal, mesial, lingual) are evaluated 0= Normal gingiva

  1. Mild inflammation - slight discoloration, slight edema. There is no bleeding after probing.
  2. Moderate inflammation - redness, edema and shine. Bleeding after probing.
  3. Severe inflammation - marked redness and edema. Ulceration. Tendency to spontaneous bleeding.
baseline, 1st month, 3rd month and 6th month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 24, 2024

Primary Completion (Actual)

February 1, 2025

Study Completion (Actual)

February 7, 2025

Study Registration Dates

First Submitted

February 14, 2025

First Submitted That Met QC Criteria

February 14, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

February 14, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subgingival Plaque

Subscribe